Ovarian ablation in breast cancer, 1896 to 1998: milestones along hierarchy of evidence from case report to Cochrane review.
作者信息
Clarke M J
机构信息
Clinical Trial Service Unit, Radcliffe Infirmary, Oxford OX2 6HE.
出版信息
BMJ. 1998 Oct 31;317(7167):1246-8. doi: 10.1136/bmj.317.7167.1246.
Abstract
摘要
相似文献
1
Ovarian ablation in breast cancer, 1896 to 1998: milestones along hierarchy of evidence from case report to Cochrane review.1896年至1998年乳腺癌的卵巢切除术：从病例报告到Cochrane系统评价的证据等级里程碑
BMJ. 1998 Oct 31;317(7167):1246-8. doi: 10.1136/bmj.317.7167.1246.
2
Oophorectomy for breast cancer: history revisited.
J Natl Cancer Inst. 2002 Oct 2;94(19):1433-4. doi: 10.1093/jnci/94.19.1433.
3
The history of development and perspectives of breast cancer surgery.
Przegl Lek. 2000;57 Suppl 5:110-2.
4
Breast cancer-The catalyst of contemporary trials design.乳腺癌——当代试验设计的催化剂。
J Surg Oncol. 2022 Jan;125(1):7-16. doi: 10.1002/jso.26722.
5
Breast cancer detection and treatment: a personal and historical perspective.
Arch Surg. 2003 Apr;138(4):397-408. doi: 10.1001/archsurg.138.4.397.
6
Adjuvant endocrine therapy for premenopausal women with early breast cancer.绝经前早期乳腺癌患者的辅助内分泌治疗
Breast Cancer Res. 2007;9(6):115. doi: 10.1186/bcr1830.
7
[Centenary of Fibiger's controlled clinical trial].[菲比格对照临床试验百年纪念]
Ugeskr Laeger. 1998 Dec 14;160(51):7407-8.
8
Preserving life and conserving the breast.挽救生命与保留乳房。
Lancet Oncol. 2009 Jul;10(7):736. doi: 10.1016/S1470-2045(09)70117-2.
9
100 years of the endocrine battle against breast cancer.内分泌治疗乳腺癌的百年抗争
Lancet. 1996 Jun 29;347(9018):1780-1. doi: 10.1016/s0140-6736(96)91612-8.
10
The evolution of surgery for breast cancer.乳腺癌手术的演变
Surg Oncol Clin N Am. 2005 Jul;14(3):479-98, vi. doi: 10.1016/j.soc.2005.04.006.
引用本文的文献
1
Postural orthostatic tachycardia syndrome after COVID-19 vaccination: A systematic review.接种 COVID-19 疫苗后出现的体位性心动过速综合征：系统评价。
BMC Cardiovasc Disord. 2024 Nov 13;24(1):643. doi: 10.1186/s12872-024-04315-x.
2
PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging.用于雌激素、雄激素和孕激素受体的PET成像剂（FES、FFNP和FDHT），通过功能成像改善乳腺癌和前列腺癌的管理。
Cancers (Basel). 2020 Jul 23;12(8):2020. doi: 10.3390/cancers12082020.
3
The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.通过功能成像改善乳腺癌管理的探索：16α-[F]氟雌二醇（FES）的发现和发展，一种用于雌激素受体的 PET 放射性示踪剂，历史回顾。
Nucl Med Biol. 2021 Jan;92:24-37. doi: 10.1016/j.nucmedbio.2020.02.007. Epub 2020 Feb 22.
4
Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.卵巢抑制用于激素受体阳性早期乳腺癌的辅助治疗。
Cochrane Database Syst Rev. 2020 Mar 6;3(3):CD013538. doi: 10.1002/14651858.CD013538.
5
Change in risk of breast cancer after receiving hormone replacement therapy by considering effect-modifiers: a systematic review and dose-response meta-analysis of prospective studies.通过考虑效应修饰因素评估接受激素替代疗法后乳腺癌风险的变化：前瞻性研究的系统评价和剂量反应荟萃分析
Oncotarget. 2017 Aug 11;8(46):81109-81124. doi: 10.18632/oncotarget.20154. eCollection 2017 Oct 6.
6
Evaluating the Survival Benefit Following Ovarian Function Suppression in Premenopausal Patients with Hormone Receptor Positive Early Breast Cancer.评估激素受体阳性早期乳腺癌绝经前患者卵巢功能抑制后的生存获益。
Sci Rep. 2016 May 27;6:26627. doi: 10.1038/srep26627.
7
Adjuvant hormonal therapy in premenopausal women with breast cancer.绝经前乳腺癌女性的辅助激素治疗。
Indian J Med Paediatr Oncol. 2015 Oct-Dec;36(4):195-200. doi: 10.4103/0971-5851.171530.
8
Ovarian Ablation Using Goserelin Improves Survival of Premenopausal Patients with Stage II/III Hormone Receptor-Positive Breast Cancer without Chemotherapy-Induced Amenorrhea.使用戈舍瑞林进行卵巢去势可提高II/III期激素受体阳性乳腺癌绝经前患者的生存率，且不会导致化疗引起的闭经。
Cancer Res Treat. 2015 Jan;47(1):55-63. doi: 10.4143/crt.2013.165. Epub 2014 Aug 21.
9
Incidence, time trends, laterality, indications, and pathological findings of unilateral oophorectomy before menopause.绝经前单侧卵巢切除术的发病率、时间趋势、左右侧别、手术指征及病理结果
Menopause. 2014 May;21(5):442-9. doi: 10.1097/GME.0b013e3182a3ff45.
10
Adjuvant endocrine therapy for premenopausal women with breast cancer.绝经前乳腺癌患者的辅助内分泌治疗。
Breast. 2009 Oct;18 Suppl 3(0 3):S122-30. doi: 10.1016/S0960-9776(09)70286-3.
本文引用的文献
1
The Treatment of Inoperable Carcinoma of the Female Mamma.女性乳房无法手术切除的癌肿的治疗
Glasgow Med J. 1911 Aug;76(2):81-87.
2
On the Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment, with Illustrative Cases.论乳癌不可手术病例的治疗：一种新治疗方法的建议及实例说明
Trans Med Chir Soc Edinb. 1896;15:153-179.
3
Clinical trials in malignant disease. Part II-breast cancer: value of irradiation of the ovaries.恶性疾病的临床试验。第二部分——乳腺癌：卵巢照射的价值
J Fac Radiol. 1959 Jul;10:130-3.
4
An Analysis of Ninety-nine Cases of Inoperable Carcinoma of the Breast treated by Oophorectomy.卵巢切除术治疗99例不可手术乳腺癌的分析
Med Chir Trans. 1905;88:147-89.
5
Carcinoma of the breast; results, evaluation of X-radiation, and relation of age and surgical castration to length of survival.乳腺癌；结果、X线放疗评估以及年龄和手术去势与生存时长的关系
Surg Gynecol Obstet. 1953 Oct;97(4):508-16.
6
Individual patient data meta-analysis in cancer.癌症中的个体患者数据荟萃分析。
Br J Cancer. 1998 Jun;77(11):2036-44. doi: 10.1038/bjc.1998.339.
7
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.他莫昔芬用于早期乳腺癌：随机试验综述。早期乳腺癌试验者协作组
Lancet. 1998 May 16;351(9114):1451-67.
8
9
Statistical and theoretical considerations in meta-analysis.Meta分析中的统计学与理论考量
J Clin Epidemiol. 1995 Jan;48(1):133-46; discussion 147. doi: 10.1016/0895-4356(94)00136-e.
10
David Byar as a teacher.大卫·拜尔作为一名教师。
Control Clin Trials. 1995 Aug;16(4):202-11. doi: 10.1016/s0197-2456(95)80006-9.
Zotero 插件